SCHEMBL23849282

SCHEMBL23849282

Fc1ccc(N(c2ccccc2)c2cc(-c3ccccc3)c3ccc4c(N(c5ccccc5)c5ccc(F)cc5)cc(-c5ccccc5)c5ccc2c3c54)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 6/20 0.35
METAP2 P50579 1/20 0.34
GRM2 Q14416 2/20 0.33
MAP2K4 P45985 1/20 0.33
MKNK1 Q9BUB5 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32
CYP2C19 P33261 1/20 0.32
PTK2B Q14289 1/20 0.32
TOP1 P11387 1/20 0.31
GCGR P47871 1/20 0.31
MAPK14 Q16539 1/20 0.31
PTGS1 P23219 2/20 0.31
PTGS2 P35354 2/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15042301 0.98 METAP2 (0.35) PTGDR2METAP2GRM2MAP2K4MKNK1
SCHEMBL15042299 0.91 BACE1 (0.34) CYP1A2CYP2C9HPGDCYP2C19TSHR
SCHEMBL12011512 0.91 BACE1 (0.34) CYP1A2CYP2C9HPGDCYP2C19TSHR
SCHEMBL17263977 0.88 ALDH1A1 (0.36) CYP1A2CYP2C9HPGDCYP2C19MAPK1
SCHEMBL15042343 0.87 IMPDH2 (0.33) CYP1A2CYP2C9HPGDCYP2C19MAPK1
SCHEMBL15042297 0.86 MAPT (0.33) PTGDR2METAP2MAP2K4HPGD
SCHEMBL12700367 0.85 KDM4E (0.33) PTGDR2CYP1A2CYP2C9HPGDCYP2C19
SCHEMBL12576974 0.85 ALDH1A1 (0.35) METAP2HPGDCYP2C19MAPK1KMT2A
SCHEMBL23849288 0.84 KIF11 (0.42) PTGDR2METAP2TOP1TSHR
SCHEMBL13321201 0.84 GRM2 (0.39) GRM2HPGDPTK2BGCGRMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210408386-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2021-12-30 US disclosed
US-20210320265-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2021-10-14 US disclosed
US-20210296589-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2021-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210296589-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME OCIAD1, OCIAD2, BRD1 PTGDR2 1740/4885METAP2 3735/4885GRM2 4208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.